Translational Trials Development and Support Laboratory
Faculty Director
Lilith Reeves, MS
Purpose
Clinical research trial monitoring may require non-standard assays done in compliance with Good Clinical Practices. Many of these assays may currently be available only at the research level, which fails to meet standard operating procedure (SOP) and control requirements. Assays may alternatively be available in compliance with the Good Laboratory Practice (GLP), which includes unnecessary documentation and practices (and associated added costs). The TTDSL was created to provide tailored assays at a level of appropriate compliance to support the development and conduct of clinical trials.
Commonly required assays currently available on a routine basis include
- Endotoxin
- Colony forming units with or without drug resistance
- Mycoplasma
- Quantitative PCR
- Insertion site analysis (Linear amplification mediated PCR and Linear mediated PCR)
- Fanconi Anemia Complementation
- Research level testing for bacterial and fungal contaminants
- Vector titration
- RCR/RCL testing
Additional assays may be developed to provide specific needs.
Location
Division of Experimental Hematology-6th floor Research Foundation Building, Room 6543
Fee Structure
Fees have been designed to provide recovery of costs and are tailored to specific assay modifications as necessary. Fees for standard assyas are listed on the TTDSL menu of services. Contact Lilith Reeves, 513-636-3468 for assay modification/development and associated costs.
Specific Core Request Information
Core Contacts: Lilith Reeves, 513-636-3468; Elke Will, PhD, 513-636-5998
